Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC

by Pedro Rocha, MD, Didac Ramal, MD, Enric Ripoll, MD, Laura Moliner, MD, Alex Corbera, MD, Max Hardy-Werbin, MD, PhD, Mayra Orrillo, MD, Álvaro Taus, MD, Flavio Zuccarino, MD, Joan Gibert, Júlia Perera-Bel, David Casadevall, MD, PhD, Edurne Arriola, MD, PhD
Published 2021-01-01